Who owns OUTLOOK THERAPEUTICS INC COM?
- Ticker: OTLK
- CUSIP Number: 69012t305
Tip: Access positions for across all investors
Analyze quarterly positions in Outlook Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Outlook Therapeutics stock
Who bought or sold OUTLOOK THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 4.2M | $858k | 100% | Mar 2026 |
|
| Vanguard Capital Management | 2.0M | $405k | 100% | Mar 2026 |
|
| Vanguard Group | 1.5M | $2.3M | 9% | Dec 2025 |
|
| Sio Capital Management | 1.1M | $1.8M | 100% | Dec 2025 |
|
| Susquehanna International | 733k | $1.2M | 211% | Dec 2025 |
|
| Gilpin Wealth Management | 710k | $146k | 100% | Mar 2026 |
|
| Geode Capital Management | 604k | $124k | 91% | Mar 2026 |
|
| BlackRock | 478k | $98k | 18% | Mar 2026 |
|
| Commonwealth Equity Services | 470k | $97k | 318% | Mar 2026 |
|
| Marshall Wace | 299k | $472k | 100% | Dec 2025 |
|
| Warberg Asset Management | 275k | $56k | 100% | Mar 2026 |
|
| Nine Masts Capital | 233k | $48k | 100% | Mar 2026 |
|
| Connective Capital Management | 200k | $41k | 100% | Mar 2026 |
|
| Citadel Advisors | 195k | $40k | -81% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 177k | $36k | 100% | Mar 2026 |
|
| State Street Corporation | 163k | $258k | 117% | Dec 2025 |
|
| UBS Group | 133k | $27k | -36% | Mar 2026 |
|
| Group One Trading | 114k | $23k | 207% | Mar 2026 |
|
| Simplex Trading | 106k | $167k | 19% | Dec 2025 |
|
| Hrt Financial | 68k | $13k | 100% | Mar 2026 |
|
| Northern Trust | 67k | $107k | 159% | Dec 2025 |
|
| Jane Street | 55k | $11k | -66% | Mar 2026 |
|
| LPL Financial | 34k | $6.9k | 54% | Mar 2026 |
|
| JustInvest | 32k | $6.5k | 102% | Mar 2026 |
|
| XTX Topco | 30k | $48k | 175% | Dec 2025 |
|
| CI Private Wealth | 30k | $6.2k | 100% | Mar 2026 |
|
| Point72 Asset Management | 29k | $6.0k | 100% | Mar 2026 |
|
| Christensen, King & Associates Investment Services | 28k | $5.8k | 0% | Mar 2026 |
|
| Pnc Financial Services | 25k | $5.2k | 67% | Mar 2026 |
|
| Flower City Capital | 20k | $4.1k | 0% | Mar 2026 |
|
| Oppenheimer & Co | 16k | $3.2k | 100% | Mar 2026 |
|
| Intl Fcstone | 13k | $2.7k | 100% | Mar 2026 |
|
| Tower Research Capital | 13k | $20k | 100% | Dec 2025 |
|
| Harbour Investments | 12k | $2.5k | 21% | Mar 2026 |
|
| Goldman Sachs Group | 10k | $2.1k | -78% | Mar 2026 |
|
| Advisor Group Holdings | 9.0k | $14k | 0% | Dec 2025 |
|
| Vanguard Global Advisers | 6.9k | $1.4k | 100% | Mar 2026 |
|
| Morgan Stanley | 3.8k | $783.274800 | -37% | Mar 2026 |
|
| Fortitude Family Office | 2.6k | $526.124000 | 502% | Mar 2026 |
|
| Jones Financial Companies, L.L | 2.5k | $4.0k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 2.5k | $510.384000 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 2.3k | $472.057600 | 8% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 1.3k | $262.006400 | 0% | Mar 2026 |
|
| Ancora Advisors | 1.1k | $226.050000 | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 696.00 | $143.028000 | 0% | Mar 2026 |
|
| FMR | 606.00 | $954.753000 | 472% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 305.00 | $63.013000 | 0% | Mar 2026 |
|
| CWM | 283.00 | $0 | 0% | Dec 2025 |
|
| SBI Securities | 222.00 | $45.998400 | 6% | Mar 2026 |
|
| Armstrong Advisory Group | 179.00 | $36.999300 | 0% | Mar 2026 |
|
| Larson Financial Group | 100.00 | $158.000000 | 0% | Dec 2025 |
|
| Royal Bank of Canada | 85.00 | $0 | -98% | Mar 2026 |
|
| Prestige Wealth Management Group | 62.00 | $13.001400 | 0% | Mar 2026 |
|
| IFP Advisors | 50.00 | $10.000000 | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 14.00 | $3.000200 | 0% | Mar 2026 |
|
| Bogart Wealth | 5.00 | $1.000000 | 100% | Mar 2026 |
|
| Barclays | 1.00 | $2.000000 | 0% | Dec 2025 |
|
Who sold out of Outlook Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schonfeld Strategic Advisors | Dec 2025 | 2.4M | $3.9M |
| Millennium Management | Dec 2025 | 165k | $260k |
| ADAR1 Capital Management | Dec 2025 | 100k | $158k |
| Scotia Capital | Dec 2025 | 74k | $117k |
| LVW Advisors | Dec 2025 | 48k | $76k |
| Vontobel Holding | Dec 2025 | 40k | $63k |
| Qube Research & Technologies | Sep 2025 | 13k | $14k |
| Squarepoint Ops | Dec 2025 | 12k | $19k |
| Tudor Investment Corporation | Dec 2025 | 10k | $16k |
| International Assets Investment Management | Dec 2025 | 1.0k | $1.6k |
| SHP Wealth Management | Dec 2025 | 59.00 | $93.001700 |
| Jpmorgan Chase & Co | Sep 2025 | 15.00 | $16.000500 |